Fear of progression in parents of childhood cancer survivors: prevalence and associated factors.


Journal

Journal of cancer survivorship : research and practice
ISSN: 1932-2267
Titre abrégé: J Cancer Surviv
Pays: United States
ID NLM: 101307557

Informations de publication

Date de publication:
08 2022
Historique:
received: 22 03 2021
accepted: 14 06 2021
pubmed: 25 7 2021
medline: 23 7 2022
entrez: 24 7 2021
Statut: ppublish

Résumé

Recent research demonstrated that fear of progression (FoP) is a major burden for adult cancer survivors. However, knowledge on FoP in parents of childhood cancer survivors is scarce. This study aimed to determine the proportion of parents who show dysfunctional levels of FoP, to investigate gender differences, and to examine factors associated with FoP in mothers and fathers. Five hundred sixteen parents of pediatric cancer survivors (aged 0-17 years at diagnosis of leukemia or central nervous system (CNS) tumor) were consecutively recruited after the end of intensive cancer treatment. We conducted hierarchical multiple regression analyses for mothers and fathers and integrated parent-, patient-, and family-related factors in the models. Significantly more mothers (54%) than fathers (41%) suffered from dysfunctional levels of FoP. Maternal FoP was significantly associated with depression, a medical coping style, a child diagnosed with a CNS tumor in comparison to leukemia, and lower family functioning (adjusted R FoP represents a great burden for parents of pediatric cancer survivors. We identified associated factors of parental FoP. Some of these factors can be targeted by health care professionals within psychosocial interventions and others can provide an indication for an increased risk for higher levels of FoP. Psychosocial support targeting FoP in parents of childhood cancer survivors is highly indicated.

Identifiants

pubmed: 34302272
doi: 10.1007/s11764-021-01076-w
pii: 10.1007/s11764-021-01076-w
pmc: PMC9300493
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

823-833

Informations de copyright

© 2021. The Author(s).

Références

Psychooncology. 2016 Jul;25(7):808-14
pubmed: 26477788
Pediatr Blood Cancer. 2011 Apr;56(4):524-31
pubmed: 21298736
Psychooncology. 2007 Mar;16(3):214-23
pubmed: 16906624
Health Qual Life Outcomes. 2011 Nov 23;9:102
pubmed: 22111939
J Psychosom Res. 2018 Nov;114:18-24
pubmed: 30314574
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Acta Oncol. 2013 Aug;52(6):1102-9
pubmed: 23384721
Psychooncology. 2019 Sep;28(9):1901-1909
pubmed: 31276614
Cancer Nurs. 2008 Jul-Aug;31(4):292-301
pubmed: 18600116
PLoS One. 2016 Jun 07;11(6):e0157076
pubmed: 27272318
Health Qual Life Outcomes. 2009 Aug 26;7:77
pubmed: 19709410
Support Care Cancer. 2015 Jun;23(6):1579-87
pubmed: 25412727
J Pediatr Oncol Nurs. 2017 Sep/Oct;34(5):358-366
pubmed: 28443699
Klin Padiatr. 2015 May;227(3):151-6
pubmed: 25811743
Psychother Psychosom Med Psychol. 2012 Sep-Oct;62(9-10):344-51
pubmed: 23027388
J Psychosoc Oncol. 2007;25(3):113-22
pubmed: 19341017
Recent Results Cancer Res. 2018;210:13-33
pubmed: 28924677
Psychooncology. 2020 Feb;29(2):430-436
pubmed: 31713279
Psychooncology. 2013 Jan;22(1):1-11
pubmed: 22232030
Behav Med. 2011 Jul;37(3):95-104
pubmed: 21895427
J Psychosoc Oncol. 2021;39(1):89-104
pubmed: 32589114
Cancer Treat Rev. 2010 Jun;36(4):277-85
pubmed: 20231056
Fam Process. 2020 Sep;59(3):1225-1242
pubmed: 31408204
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
J Affect Disord. 2004 Jul;81(1):61-6
pubmed: 15183601
BMJ Open. 2020 Mar 8;10(3):e033730
pubmed: 32152163
J Cancer Surviv. 2013 Sep;7(3):300-22
pubmed: 23475398
Z Psychosom Med Psychother. 2006;52(3):274-88
pubmed: 17156600
Klin Padiatr. 2018 Apr;230(3):130-137
pubmed: 29672778
Support Care Cancer. 2010 Apr;18(4):471-9
pubmed: 19865833
PLoS One. 2014 Jul 24;9(7):e103340
pubmed: 25058607
Psychooncology. 2020 Nov;29(11):1959-1967
pubmed: 33068463
Psychooncology. 2020 Oct;29(10):1678-1685
pubmed: 32779255
Psychooncology. 2014 May;23(5):547-54
pubmed: 24293081
BMJ Open. 2017 Aug 11;7(8):e014505
pubmed: 28801389
J Psychosom Res. 2018 Apr;107:7-13
pubmed: 29502766
J Psychosom Res. 2017 Feb;93:110-117
pubmed: 28107886
Gen Hosp Psychiatry. 2006 Jan-Feb;28(1):71-7
pubmed: 16377369
Psychother Psychosom. 2010;79(1):31-8
pubmed: 19887889
J Adv Nurs. 2002 Jun;38(6):598-606
pubmed: 12067399
J Pediatr Psychol. 2004 Apr-May;29(3):211-9
pubmed: 15131138

Auteurs

Mona L Peikert (ML)

Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

Laura Inhestern (L)

Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. l.inhestern@uke.de.

Konstantin A Krauth (KA)

Department of Pediatrics, Pediatric Hematology and Oncology, Klinik Bad Oexen, Oexen 27, 32549, Bad Oeynhausen, Germany.

Gabriele Escherich (G)

Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

Stefan Rutkowski (S)

Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

Daniela Kandels (D)

Swabian Children's Cancer Center, Medical Faculty, University of Augsburg, Stenglinstraße 2, 86156, Augsburg, Germany.

Louis J Schiekiera (LJ)

Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

Corinna Bergelt (C)

Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH